Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Melanoma risk associated with MC1R gene variants in Latvia and the functional analysis of rare variants

  • Aija Ozola*
  • , Kristine Azarjana
  • , Simona Doniņa
  • , Guna Proboka
  • , Ilona Mandrika
  • , Ramona Petrovska
  • , Ingrida Čema
  • , Olita Heisele
  • , Ludmila Eņģele
  • , Baiba Štreinerte
  • , Dace Pjanova
  • *Šī darba korespondējošais autors
  • Latvian Institute of Organic Synthesis
  • Riga Stradins University
  • Riga East University Hospital

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

7 Atsauces (Scopus)

Kopsavilkums

To evaluate the association of melanocortin 1 receptor gene (. MC1R) variants with melanoma risk in a Latvian population, the MC1R gene was sequenced in 200 melanoma patients and 200 control persons. A functional study of previously uncharacterized, rare MC1R variants was also performed. In total, 26 different MC1R variants, including two novel variants Val165Ile and Val188Ile, were detected. The highest risk of melanoma was associated with the Arg151Cys variant (odds ratio (OR) 4.47, 95% confidence interval (CI) 2.19-9.14, P < 0.001). A gene dosage effect was observed, with melanoma risk for carriers of two variants being twice (OR 3.98, 95% CI 2.15-7.38, P < 0.001) that of carriers of one variant (OR 1.98, 95% CI 1.26-3.11, P = 0.003). After stratification according to the pigmentation phenotype, the risk of melanoma remained in groups with otherwise protective phenotypes. Functional analyses of eight previously uncharacterized MC1R variants revealed that a subset of them is functionally relevant. Our results support the contribution of MC1R variants to a genetic predisposition to melanoma in Latvia.

OriģinālvalodaAngļu
Lapas (no-līdz)81-91
Lapu skaits11
ŽurnālsCancer Genetics
Sējums206
Izdevuma numurs3
DOIs
Publikācijas statussPublicēts - marts 2013
Ārēji publicētsJā

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Melanoma risk associated with MC1R gene variants in Latvia and the functional analysis of rare variants”. Kopā tie veido unikālu nospiedumu.

Citēt šo